Food allergy drug developer Alladapt raised $119M in new funding
June 22, 2022 at 18:52 PM EDT
The funding comes as the Menlo Park company has begun a clinical trial and is building a manufacturing plant.
|
||||||||||||
![]() |
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |